Based on the Bioceres Crop Solutions Corp stock forecast from 4 analysts, the average analyst target price for Bioceres Crop Solutions Corp is USD 14.94 over the next 12 months. Bioceres Crop Solutions Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Bioceres Crop Solutions Corp is Bullish , which is based on 12 positive signals and 3 negative signals. At the last closing, Bioceres Crop Solutions Corp’s stock price was USD 7.26. Bioceres Crop Solutions Corp’s stock price has changed by +0.00% over the past week, -10.26% over the past month and -32.02% over the last year.
No recent analyst target price found for Bioceres Crop Solutions Corp
No recent average analyst rating found for Bioceres Crop Solutions Corp
Company Overview Bioceres Crop Solutions Corp
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina. Read Less
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed...Read More
Frequently Asked Questions About Bioceres Crop Solutions Corp (BIOX) Stock
Based on ratings from 4 analysts Bioceres Crop Solutions Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 8 buy, sell and hold ratings.
Unfortunately we do not have enough data on BIOX's stock to indicate if its a good dividend stock.
Based on targets from 4 analysts, the average taret price for BIOX is USD 14.94 over the next 12 months. The maximum analyst target price is USD 17 while the minimum anlayst target price is USD 12.5.
BIOX stock's Price/Earning ratio is 147.60.
Our analysis grades BIOX stock's Price / Earning ratio at F. This means that BIOX stock's Price/Earning ratio is above 50% of the stocks in the Agricultural Inputs sector in the NSD exchange.
Based on this BIOX may be fairly valued for its sector
The last closing price of BIOX's stock was USD 7.26.
The most recent market capitalization for BIOX is USD 0.45B.
Based on targets from 4 analysts, the average taret price for BIOX is projected at USD 14.94 over the next 12 months.
This means that BIOX's stock price may go up by +105.75% over the next 12 months.
We can't find any ETFs which contains Bioceres Crop Solutions Corp's stock.
As per our most recent records Bioceres Crop Solutions Corp has 0 Employees.
Bioceres Crop Solutions Corp's registered address is Ocampo 210 bis, Rosario, Argentina, 2000.
You can get more information about it from Bioceres Crop Solutions Corp's website at https://biocerescrops.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Bioceres Crop Solutions Corp (BIOX) Stock
Based on ratings from 4 analysts Bioceres Crop Solutions Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 8 buy, sell and hold ratings.
Unfortunately we do not have enough data on BIOX's stock to indicate if its a good dividend stock.
Based on targets from 4 analysts, the average taret price for BIOX is USD 14.94 over the next 12 months. The maximum analyst target price is USD 17 while the minimum anlayst target price is USD 12.5.
BIOX stock's Price/Earning ratio is 147.60.
Our analysis grades BIOX stock's Price / Earning ratio at F. This means that BIOX stock's Price/Earning ratio is above 50% of the stocks in the Agricultural Inputs sector in the NSD exchange.
Based on this BIOX may be fairly valued for its sector
The last closing price of BIOX's stock was USD 7.26.
The most recent market capitalization for BIOX is USD 0.45B.
Based on targets from 4 analysts, the average taret price for BIOX is projected at USD 14.94 over the next 12 months.
This means that BIOX's stock price may go up by +105.75% over the next 12 months.
We can't find any ETFs which contains Bioceres Crop Solutions Corp's stock.
As per our most recent records Bioceres Crop Solutions Corp has 0 Employees.
Bioceres Crop Solutions Corp's registered address is Ocampo 210 bis, Rosario, Argentina, 2000.
You can get more information about it from Bioceres Crop Solutions Corp's website at https://biocerescrops.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BIOX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
